A twice-yearly shot could help end AIDS. But will it get to everyone who needs it?
Nearly all of Latin America was excluded from the deal, sparking concern the world is missing a critical opportunity to stop ...
Medical News Today1d
Lenacapavir injection lowers HIV risk by 96%
Lenacapavir, an antiretroviral drug typically used to treat HIV infections, can also effectively prevent them, a phase 3 ...
Labroots21h
Twice Yearly Injection 96% Reduces HIV Infection Risk by 96%
A recent phase 3 trial found that twice-yearly injections of Lenacapavir reduce the risk of contracting HIV by 96%. | Drug ...
Medscape1d
HIV ‘Game-Changer’ Drug: Is Eastern Europe Missing Out?
A new, long-acting injectable to prevent HIV infection could be a “game-changer” in ending the AIDS epidemic, if all who ...
India Today on MSN1d
New injection reduces risk of HIV infection by 96%: All about it
A new HIV prevention method, Lenacapavir, administered as a twice-yearly injection, has demonstrated superior results ...
Daily11h
Clinical trial reveals twice-yearly injection to be 96% effective in HIV prevention
For oral medications that prevent new HIV infection to be effective, the patient must take certain actions, including ...
Interesting Engineering on MSN2d
From chronic to curable: Twice-yearly shot shows near-total HIV eradication
Scientists have developed Lenacapavir, a twice-yearly injection that cuts HIV infection risk by 96% in groundbreaking trials.
HIV prophylactic lenacapavir — very safe and very expensive
Health experts say lenacapavir could reduce the number of global HIV infections significantly. But it needs to be cheaper to ...
Six-Month HIV Prevention Shot Achieves 99% Efficacy in Major Study
Lenacapavir, a new twice-yearly injection, offers 96% HIV prevention efficacy, surpassing daily oral PrEP. For oral ...
HIV Breakthrough as New Injection 89% More Effective Than PrEP
"PrEP reduces the risk of getting HIV from sex by about 99 percent when taken as prescribed. Although there is less ...